QC Analyst (Cell and Gene Therapy) – Lonza in Tuas, Singapore
Lonza is currently accepting applications for the position of QC Analyst (Cell and Gene Therapy) in the Tuas area. The job type available for this position is Full-time.
We are looking for candidates who possess proficient skills and have a minimum of beginners/seniors in the respective field. In addition to technical expertise, we highly value traits such as honesty, discipline, and a strong sense of responsibility in our prospective employees.
Lonza operates within the (according to the company) industry. If you are interested in applying for this position and joining our esteemed organization, we encourage you to submit your application promptly.
Job Information
| Company: | Lonza |
| Position: | QC Analyst (Cell and Gene Therapy) |
| Region: | Singapore, Tuas |
| Education: | Confidential |
| Salary: | SGD 3.700 - SGD 5.900 per Month |
| Job Type: | Full-time |
Job Description
We are seeking a dedicated QC Analyst specializing in Cell and Gene Therapy to join our dynamic team. This position requires a strong background in quality control processes and testing methodologies specific to cell and gene therapies.
The successful candidate will ensure compliance with industry standards and regulations, perform analytical testing, and contribute to the development of quality systems.
Benefit
- Overtime bonus
- Gaining experience
- Comfortable work environment
Application Requirements
- Physically and mentally healthy
- Minimum age of 17 years
- Disciplined and punctual
- Honest and responsible
- Good personality
- Enthusiasm in working and learning
- For other requirements, please check through the job form.
Company address
| Province | Singapore |
| City | Tuas |
| Google Map | Google Map |
Job Application Information
Make sure you fill out the application form first and wait for HRD to call for an interview before you go to the company in person.
Applying for Free Jobs is free of charge.
If you find a vacancy that indicates fraud, please report it to us.
